Cited by 625

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Insulin Action in Brain Regulates Systemic Metabolism and Brain Function

Kleinridders, André, Ferris, Heather A., Cai, Weikang, Kahn, C. Ronald·2014·Diabetes

Abstract

Insulin receptors, as well as IGF-1 receptors and their postreceptor signaling partners, are distributed throughout the brain. Insulin acts on these receptors to modulate peripheral metabolism, including regulation of appetite, reproductive function, body temperature, white fat mass, hepatic glucose output, and response to hypoglycemia. Insulin signaling also modulates neurotransmitter channel activity, brain cholesterol synthesis, and mitochondrial function. Disruption of insulin action in the brain leads to impairment of neuronal function and synaptogenesis. In addition, insulin signaling modulates phosphorylation of tau protein, an early component in the development of Alzheimer disease. Thus, alterations in insulin action in the brain can contribute to metabolic syndrome, and the development of mood disorders and neurodegenerative diseases.

Verifying this paper

8 of 9 steps done · this page updates itself — you can leave and come back

  1. Registry recordVerified
  2. Full textFetching the open-access text — a few minutes for a paper we haven’t read before
  3. Reference listNot fetched yet
  4. Reference checkNot run yet for this paper
  5. StatisticsNeeds the full text
  6. ClaimsNeeds the full text
  7. Cited sourcesNeeds claims to check
  8. Self-checkNeeds the full text
  9. VerificationFindings verified

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-0568

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The increase in Angptl4 in the hypothalamus of ob/ob type 2 diabetic mice is most likely due to insulin resistance.

    “The increase in Angplt4 in type 2 diabetes in hypothalamus of ob/ob mice is most likely due to insulin resistance, since we [37,38] and others [39,40] have shown, obesity is associated with increased inflammation and mitochondrial dysfunction at the level of the hypothalamus and both of these can contribute to an altered insulin response.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 104

  1. Rask-Madsen, 2012, Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease, Arterioscler Thromb Vasc Biol, 32, 2052, 10.1161/ATVBAHA.111.241919 · DOI
  2. Belfiore, 2009, Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease, Endocr Rev, 30, 586, 10.1210/er.2008-0047 · DOI
  3. Zhao, 2004, Insulin and the insulin receptor in experimental models of learning and memory, Eur J Pharmacol, 490, 71, 10.1016/j.ejphar.2004.02.045 · DOI
  4. Dou, 2005, Insulin receptor signaling in long-term memory consolidation following spatial learning, Learn Mem, 12, 646, 10.1101/lm.88005 · DOI
  5. Brüning, 2000, Role of brain insulin receptor in control of body weight and reproduction, Science, 289, 2122, 10.1126/science.289.5487.2122 · DOI · Paper page
  6. Kappeler, 2008, Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism, PLoS Biol, 6, e254, 10.1371/journal.pbio.0060254 · DOI
  7. Heidenreich, 1986, Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain, Endocrinology, 118, 1835, 10.1210/endo-118-5-1835 · DOI
  8. McElduff, 1988, A comparison of the insulin and insulin-like growth factor I receptors from rat brain and liver, Endocrinology, 122, 1933, 10.1210/endo-122-5-1933 · DOI
  9. Bailyes, 1997, Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting, Biochem J, 327, 209, 10.1042/bj3270209 · DOI
  10. Fantin, 1999, Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 gene, Endocrinology, 140, 1329, 10.1210/endo.140.3.6578 · DOI
  11. Numan, 1999, Discrete expression of insulin receptor substrate-4 mRNA in adult rat brain, Brain Res Mol Brain Res, 72, 97, 10.1016/S0169-328X(99)00160-6 · DOI
  12. Araki, 1994, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, Nature, 372, 186, 10.1038/372186a0 · DOI · Paper page
  13. Schubert, 2003, Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation, J Neurosci, 23, 7084, 10.1523/JNEUROSCI.23-18-07084.2003 · DOI · Paper page
  14. Sadagurski, 2013, Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis, Mol Metab, 3, 55, 10.1016/j.molmet.2013.10.004 · DOI
  15. Stoica, 2011, Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage, Proc Natl Acad Sci U S A, 108, 3791, 10.1073/pnas.1014715108 · DOI · Paper page
  16. Son, 2012, Neuronal autophagy and neurodegenerative diseases, Exp Mol Med, 44, 89, 10.3858/emm.2012.44.2.031 · DOI
  17. Salcedo-Tello, 2011, GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration, Int J Alzheimers Dis, 2011, 189728, 10.4061/2011/189728 · DOI
  18. Schubert, 2004, Role for neuronal insulin resistance in neurodegenerative diseases, Proc Natl Acad Sci U S A, 101, 3100, 10.1073/pnas.0308724101 · DOI
  19. Ren, 2013, Blunted refeeding response and increased locomotor activity in mice lacking FoxO1 in synapsin-Cre-expressing neurons, Diabetes, 62, 3373, 10.2337/db13-0597 · DOI
  20. Kim, 2012, FOXO1 in the ventromedial hypothalamus regulates energy balance, J Clin Invest, 122, 2578, 10.1172/JCI62848 · DOI
  21. Adams, 2002, Molecular psychology: roles for the ERK MAP kinase cascade in memory, Annu Rev Pharmacol Toxicol, 42, 135, 10.1146/annurev.pharmtox.42.082701.145401 · DOI
  22. Desai, 2011, Hypothalamic neurosphere progenitor cells in low birth-weight rat newborns: neurotrophic effects of leptin and insulin, Brain Res, 1378, 29, 10.1016/j.brainres.2010.12.080 · DOI
  23. Margolis, 1967, Insulin in the cerebrospinal fluid, Nature, 215, 1375, 10.1038/2151375a0 · DOI · Paper page
  24. Woods, 2003, Insulin and the blood-brain barrier, Curr Pharm Des, 9, 795, 10.2174/1381612033455323 · DOI
  25. Havrankova, 1978, Identification of insulin in rat brain, Proc Natl Acad Sci U S A, 75, 5737, 10.1073/pnas.75.11.5737 · DOI
  26. Devaskar, 1994, Insulin gene expression and insulin synthesis in mammalian neuronal cells, J Biol Chem, 269, 8445, 10.1016/S0021-9258(17)37214-9 · DOI
  27. Wang, Isolation and immortalization of MIP-GFP neurons from the hypothalamus, Endocrinology
  28. Lin, 2004, Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes, J Clin Invest, 114, 908, 10.1172/JCI22217 · DOI · Paper page
  29. Mehran, 2012, Hyperinsulinemia drives diet-induced obesity independently of brain insulin production, Cell Metab, 16, 723, 10.1016/j.cmet.2012.10.019 · DOI · Paper page
  30. Schwartz, 2000, Central nervous system control of food intake, Nature, 404, 661, 10.1038/35007534 · DOI · Paper page
  31. Biessels, 2008, Cognition and diabetes: a lifespan perspective, Lancet Neurol, 7, 184, 10.1016/S1474-4422(08)70021-8 · DOI
  32. Antenor-Dorsey, 2013, White matter microstructural integrity in youth with type 1 diabetes, Diabetes, 62, 581, 10.2337/db12-0696 · DOI
  33. den Heijer, 2003, Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI, Diabetologia, 46, 1604, 10.1007/s00125-003-1235-0 · DOI
  34. Lyoo, 2013, Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus, PLoS One, 8, e71304, 10.1371/journal.pone.0071304 · DOI
  35. Musen, 2012, Resting-state brain functional connectivity is altered in type 2 diabetes, Diabetes, 61, 2375, 10.2337/db11-1669 · DOI
  36. Biessels, 1996, Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats, Diabetes, 45, 1259, 10.2337/diab.45.9.1259 · DOI
  37. Li, 2002, Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents, Neuroscience, 113, 607, 10.1016/S0306-4522(02)00162-8 · DOI · Paper page
  38. Park, 2000, Intracerebroventricular insulin enhances memory in a passive-avoidance task, Physiol Behav, 68, 509, 10.1016/S0031-9384(99)00220-6 · DOI
  39. Biessels, 1998, Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment, Brain Res, 800, 125, 10.1016/S0006-8993(98)00510-1 · DOI
  40. Klöckener, 2011, High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons, Nat Neurosci, 14, 911, 10.1038/nn.2847 · DOI
  41. Christie, 1999, Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus, J Neurochem, 72, 1523, 10.1046/j.1471-4159.1999.721523.x · DOI
  42. Skeberdis, 2001, Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis, Proc Natl Acad Sci U S A, 98, 3561, 10.1073/pnas.051634698 · DOI
  43. van der Heide, 2005, Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner, J Neurochem, 94, 1158, 10.1111/j.1471-4159.2005.03269.x · DOI · Paper page
  44. Huang, 2004, An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus, J Neurochem, 89, 217, 10.1111/j.1471-4159.2003.02307.x · DOI
  45. Wang, 2000, Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis, Neuron, 25, 635, 10.1016/S0896-6273(00)81066-1 · DOI
  46. Ge, 2010, Hippocampal long-term depression is required for the consolidation of spatial memory, Proc Natl Acad Sci U S A, 107, 16697, 10.1073/pnas.1008200107 · DOI
  47. Wan, 1997, Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin, Nature, 388, 686, 10.1038/41792 · DOI
  48. Chiu, 2008, Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo, Neuron, 58, 708, 10.1016/j.neuron.2008.04.014 · DOI · Paper page
  49. Lee, 2005, Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway, J Biol Chem, 280, 18543, 10.1074/jbc.M414112200 · DOI
  50. Unger, 1991, Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects, Prog Neurobiol, 36, 343, 10.1016/0301-0082(91)90015-S · DOI
  51. Heni, 2011, Insulin promotes glycogen storage and cell proliferation in primary human astrocytes, PLoS One, 6, e21594, 10.1371/journal.pone.0021594 · DOI
  52. Ji, 2011, Insulin increases glutamate transporter GLT1 in cultured astrocytes, Biochem Biophys Res Commun, 405, 691, 10.1016/j.bbrc.2011.01.105 · DOI
  53. Suzuki, 2010, Diabetes and insulin in regulation of brain cholesterol metabolism, Cell Metab, 12, 567, 10.1016/j.cmet.2010.11.006 · DOI · Paper page
  54. Stobart, 2013, Multifunctional role of astrocytes as gatekeepers of neuronal energy supply, Front Cell Neurosci, 7, 38, 10.3389/fncel.2013.00038 · DOI
  55. Bernardinelli, 2014, Astrocyte-synapse structural plasticity, Neural Plast, 2014, 232105, 10.1155/2014/232105 · DOI
  56. Dong, 2001, Immune function of astrocytes, Glia, 36, 180, 10.1002/glia.1107 · DOI
  57. Fisher, 2003, Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production, J Clin Invest, 111, 463, 10.1172/JCI16426 · DOI
  58. Obici, 2002, Hypothalamic insulin signaling is required for inhibition of glucose production, Nat Med, 8, 1376, 10.1038/nm1202-798 · DOI · Paper page
  59. Diggs-Andrews, 2010, Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia, Diabetes, 59, 2271, 10.2337/db10-0401 · DOI
  60. Koch, 2008, Central insulin action regulates peripheral glucose and fat metabolism in mice, J Clin Invest, 118, 2132
  61. Biggers, 1989, Role of brain in counterregulation of insulin-induced hypoglycemia in dogs, Diabetes, 38, 7, 10.2337/diab.38.1.7 · DOI
  62. Fisher, 2005, Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia, Diabetes, 54, 1447, 10.2337/diabetes.54.5.1447 · DOI
  63. Sanchez-Alavez, 2011, Insulin-like growth factor 1-mediated hyperthermia involves anterior hypothalamic insulin receptors, J Biol Chem, 286, 14983, 10.1074/jbc.M110.188540 · DOI
  64. Bamshad, 1999, CNS origins of the sympathetic nervous system outflow to brown adipose tissue, Am J Physiol, 276, R1569
  65. Burks, 2000, IRS-2 pathways integrate female reproduction and energy homeostasis, Nature, 407, 377, 10.1038/35030105 · DOI
  66. Brothers, 2010, Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor, Cell Metab, 12, 295, 10.1016/j.cmet.2010.06.010 · DOI
  67. Frölich, 1999, A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer’s disease, Ann N Y Acad Sci, 893, 290, 10.1111/j.1749-6632.1999.tb07839.x · DOI
  68. Sandyk, 1993, The relationship between diabetes mellitus and Parkinson’s disease, Int J Neurosci, 69, 125, 10.3109/00207459309003322 · DOI
  69. Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease—is this type 3 diabetes?, J Alzheimers Dis, 7, 63, 10.3233/JAD-2005-7107 · DOI · Paper page
  70. Claxton, 2013, Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease, J Alzheimers Dis, 35, 789, 10.3233/JAD-122308 · DOI · Paper page
  71. de la Monte, 2012, Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease, Curr Alzheimer Res, 9, 35, 10.2174/156720512799015037 · DOI
  72. Carro, 2002, Serum insulin-like growth factor I regulates brain amyloid-beta levels, Nat Med, 8, 1390, 10.1038/nm1202-793 · DOI
  73. Carro, 2006, Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis, Neurobiol Aging, 27, 1250, 10.1016/j.neurobiolaging.2005.06.015 · DOI
  74. Gasparini, 2001, Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling, J Neurosci, 21, 2561, 10.1523/JNEUROSCI.21-08-02561.2001 · DOI
  75. Stöhr, 2013, Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease, Age (Dordr), 35, 83, 10.1007/s11357-011-9333-2 · DOI
  76. Bomfim, 2012, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers, J Clin Invest, 122, 1339, 10.1172/JCI57256 · DOI
  77. Yang, 2013, Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes, J Alzheimers Dis, 33, 329, 10.3233/JAD-2012-121294 · DOI
  78. Francis, 2008, Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy, Brain, 131, 3311, 10.1093/brain/awn288 · DOI
  79. Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc Natl Acad Sci U S A, 100, 4162, 10.1073/pnas.0230450100 · DOI
  80. Iwen, 2014, Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans, J Clin Endocrinol Metab, 99, E246, 10.1210/jc.2013-3169 · DOI · Paper page
  81. Hu, 2007, Type 2 diabetes and the risk of Parkinson’s disease, Diabetes Care, 30, 842, 10.2337/dc06-2011 · DOI · Paper page
  82. Tong, 2009, Brain insulin-like growth factor and neurotrophin resistance in Parkinson’s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity, J Alzheimers Dis, 16, 585, 10.3233/JAD-2009-0995 · DOI
  83. Wang, 2014, Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice, Exp Neurol, 251, 22, 10.1016/j.expneurol.2013.11.001 · DOI
  84. Chung, 2011, Direct interaction of α-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease, Neurosignals, 19, 86, 10.1159/000325028 · DOI
  85. Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat Rev Neurol, 9, 106, 10.1038/nrneurol.2012.263 · DOI · Paper page
  86. Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science, 294, 1354, 10.1126/science.294.5545.1354 · DOI · Paper page
  87. Suzuki, 2013, Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function, PLoS Biol, 11, e1001532, 10.1371/journal.pbio.1001532 · DOI
  88. Hoekstra, 2011, Mitochondrial therapeutics in Alzheimer’s disease and Parkinson’s disease, Alzheimers Res Ther, 3, 21, 10.1186/alzrt83 · DOI
  89. Mann, 1999, Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior, Neuropsychopharmacology, 21, 99S, 10.1016/S0893-133X(99)00040-8 · DOI
  90. Figlewicz, 1994, Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra, Brain Res, 644, 331, 10.1016/0006-8993(94)91698-5 · DOI
  91. Williams, 2007, Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine, PLoS Biol, 5, e274, 10.1371/journal.pbio.0050274 · DOI
  92. Fernstrom, 1971, Brain serotonin content: increase following ingestion of carbohydrate diet, Science, 174, 1023, 10.1126/science.174.4013.1023 · DOI
  93. Haider, 2013, Streptozotocin-induced insulin deficiency leads to development of behavioral deficits in rats, Acta Neurol Belg, 113, 35, 10.1007/s13760-012-0121-2 · DOI
  94. Sharma, 2010, Neurobehavioral deficits in db/db diabetic mice, Physiol Behav, 101, 381, 10.1016/j.physbeh.2010.07.002 · DOI
  95. Gupta, 2014, Antidepressant effects of insulin in streptozotocin induced diabetic mice: modulation of brain serotonin system, Physiol Behav, 129, 73, 10.1016/j.physbeh.2014.02.036 · DOI
  96. Sharma, 2012, Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice, J Psychopharmacol, 26, 724, 10.1177/0269881111434620 · DOI
  97. Tatar, 2001, A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function, Science, 292, 107, 10.1126/science.1057987 · DOI
  98. Blüher, 2003, Extended longevity in mice lacking the insulin receptor in adipose tissue, Science, 299, 572, 10.1126/science.1078223 · DOI · Paper page
  99. Kleinridders, 2009, MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity, Cell Metab, 10, 249, 10.1016/j.cmet.2009.08.013 · DOI · Paper page
  100. Salway, 2011, Higher levels of heat shock proteins in longer-lived mammals and birds, Mech Ageing Dev, 132, 287, 10.1016/j.mad.2011.06.002 · DOI
  101. Willcox, 2008, FOXO3A genotype is strongly associated with human longevity, Proc Natl Acad Sci U S A, 105, 13987, 10.1073/pnas.0801030105 · DOI · Paper page
  102. Tennant, 2013, Diabetes augments in vivo microvascular blood flow dynamics after stroke, J Neurosci, 33, 19194, 10.1523/JNEUROSCI.3513-13.2013 · DOI
  103. Li, 2013, Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats, Brain Res, 1541, 106, 10.1016/j.brainres.2013.10.021 · DOI
  104. Wang, 2011, Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity, Cell Metab, 13, 105, 10.1016/j.cmet.2010.12.006 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Kleinridders, A., Ferris, H. A., Cai, W., & Kahn, C. R.
Affiliations
Section on Integrative Physiology and Metabolism, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA
Venue
Diabetes
Published
2014-06-14
Volume
63
Issue
7
Pages
2232-2243
ISSN
  • 0012-1797
  • 1939-327X
Cited by
625
References
22
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review